Redcliffe Hospital
Redcliffe, Queensland 4020
3 studies enrolling now · 11 studies all time
What they study most
Atrial Fibrillation, Cardiovascular Disease, Colonic Cancer, Community-acquired Pneumonia, Influenza, COVID-19, Hypercholesterolemia, Melanoma, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer Metastatic, Rectal Cancer, Respiratory Syncytial Virus Infection, Staphylococcus Aureus Bacteremia
Studies at this site
- Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress — Recruiting now
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
- Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial — Stopped early
- A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) — Completed
- Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
- A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed
- The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection — Completed
- The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma — Stopped early